Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion

Will the coming wave of gene therapies have a Sovaldi-like impact?

  • Biopharma
The first approval of a gene therapy for congenital disease in the US …

Read more